Calidi Biotherapeutics
CLDI----
Calidi Biotherapeutics (CLDI)
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers C...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Calidi Biotherapeutics Analyst Rating
View MoreForecast & Rating
Jul 22, 2025Price forecast
$120.00109393.43%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 5 hours ago
Calidi Biotherapeutics targets Q1 2027 clinic entry for CLD-401 cancer program
- Global Report · 1 day ago, 04:18 AM
Market Signals: How a USD 4.3B Pact and AI Capex Reshape Sector Expectations
- Global Report · 1 day ago, 04:14 AM
The Biotech Survival Charade: Stop Buying the "AI Pivot" Hype
- Global Report · 2 days ago, 04:17 AM
Inside the Biotech Sector's Recent Clinical Catalyst Wave
- Global Report · 2 days ago, 04:13 AM
Sector Watch: Wix's AI Overhaul and Crypto Pivots in Small-Cap Space
- Global Report · Jul 24 at 04:13 AM
The AI Spillover: How the Market's Edges are Rewiring Real Infrastructure
